Increasing the Removal of Large Solutes by Kidney Replacement Therapy

Area of Science:

• Nephrology
• Biochemistry

Background:

• Kidney failure leads to the accumulation of solutes across a wide size range (40-40,000 Da).
• The clearance of these solutes during dialysis decreases with increasing molecular size, contributing to patient illness.
• Beta-2 microglobulin (ß2 M) amyloidosis highlighted the clinical significance of larger solute accumulation.

Purpose of the Study:

• To review the challenges and evolving strategies for removing large solutes in kidney failure.
• To discuss the limitations of current dialysis techniques in clearing large molecules.
• To explore emerging approaches like extended dialysis for improved solute removal.

Main Methods:

• Review of existing literature on solute accumulation and removal in kidney disease.
• Analysis of the impact of dialysis modality (high-flux, hemodiafiltration, peritoneal dialysis) on large solute clearance.
• Discussion of factors limiting solute removal, including nonkidney clearance and compartmentalization.

Main Results:

• High-flux dialysis and hemodiafiltration improve clearance of larger solutes but have limitations.
• Nonkidney clearance and solute compartmentalization restrict plasma level reduction.
• The clinical benefits of high-volume hemodiafiltration are not fully explained by known large solute reduction.
• Peritoneal dialysis and peptides in the middle molecular range have been under-researched.

Conclusions:

• Current dialysis methods face challenges in effectively removing all accumulating large solutes.
• Extended dialysis and hemodiafiltration show promise for enhanced clearance of larger molecules.
• Further research into nonkidney clearance mechanisms and the specific ill effects of other large solutes is crucial for developing targeted therapies.